BIS Brand

Advanced Monitoring for Improved Outcomes

Bispectral Index™ (BIS™) technology was the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain.

BIS technology enables medical professionals to reliably gauge the precise amount of anesthetic medication required by each patient, resulting in better overall patient care.

Featured Categories

Web Graphic Small for Targeted Anesthetic Dosing for BIS New Brand for RMS II

BIS™-targeted anesthetic dosing: proven benefits

Multiple peer-reviewed, published articles have concluded that BIS™ brain monitoring can help improve anesthesia-related clinical outcomes.*

[ Learn more ]

Web Graphic Small for Improved Safety and efficiency for BIS New Brand for RMS II

BIS™ technology enables improved safety and efficiency

With BIS™ technology guided care, patients wake up faster, are extubated sooner and are more oriented on arrival at the post-anesthesia care unit (PACU).1

[ Learn more ]

Related BIS™ Products

  1. Gan TJ, Glass PS, Windsor A, et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group. Anesthesiology. 1997;87(4):808-815.

*http://www.covidien.com/PACE/pages.aspx?page=ClinicalEducation/Channels/BrainFunctionMonitoring&aaid=35&lang=en-US